Commission Implementing Decision (EU) 2021/754 of 4 May 2021 concerning the extension of the action taken by the Estonian Health Board permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Article 55(1) of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2021) 3032) (Only the Estonian text is authentic)